Celladon

About:

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

Top Investors: RA Capital Management, Kleiner Perkins, Perceptive Advisors, Vivo Capital, EQT Life Sciences

Description:

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.

Total Funding Amount:

$153M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)celladon.net

Founders:

Roger Hajjar

Number of Employees:

11-50

Last Funding Date:

2015-11-18

IPO Status:

Delisted

Industries: